Ratings
0
Nobody has rated this yet. Be the first!
Works
2
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab
Risk Factor Control for Coronary Artery Disease Secondary Prevention in Large Randomized Trials
